Our approach is to fund actionable research that can produce, on a timely basis, findings that can play an important role in the quest to find a cure.
JDFAF funds basic research (laboratory studies that provide guidance for later clinical research) exploring brain function as it relates to Alzheimer's and the causal factors for the disease at the fundamental level.
Dr. Bruce Miller, Foundation Chief Medical Officer and Director of the Memory and Aging Center at the University of California, San Francisco (regarded as one of the top AD centers in the U.S.) leads the selection process of funding promising research that might expedite the finding of a cure, or delaying the onset and progression of Alzheimer’s. He is uniquely qualified, being a highly respected and accomplished researcher himself, as well as overseeing a number of Alzheimer's Disease centers across the country.
In addition, Dr. Miller has available to him, the input of the Foundation’s distinguished International Scientific Advisory Board, chaired by Nobel Laureate Dr. Stanley Prusiner.
Ongoing oversight is provided by an annual detailed written report required of each scientist regarding status of the research, including pertinent findings. This is carefully analyzed to determine if additional funding is merited.